Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00220519 · ClinicalTrials.gov registry record · NA
Lactobacillus GG Supplementation During Pediatric Burn Injuries
A NA study, sponsored by Shriners Hospitals for Children.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT00220519: Clinical Trial NA study, sponsored by Shriners Hospitals for Children.
NCT00220519 is a NA study that was terminated before completion, run by Shriners Hospitals for Children. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00220519, a NA study, was terminated before completion, sponsored by Shriners Hospitals for Children.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
Critical illness and the therapies that accompany it are associated with a disruption in the ecological equilibrium of the GI tract that can ultimately lead to infection. Lactobacillus GG, a probiotic, replenishes the healthy flora of the intestinal tract and may decrease the risk of diarrhea and infection during critical illness. However, little is known about the impact of probiotics following a burn injury and the mechanisms behind the proposed benefits. The hypothesis of this research is that Lactobacillus GG decreases the incidence of diarrhea and infection in burned children receiving antibiotic therapy. The specific aim of this research is to determine the impact of Lactobacillus GG on the incidence of diarrhea and infection among burned children (\>20% TBSA) receiving antibiotic therapy.
Interventions
- DRUG Lactobacillus GG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2004-10 |
| Est. Completion | 2005-05 |
| Phase | NA |
Why NCT00220519 stopped before completion
NCT00220519 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Lactobacillus GG is the first listed.
NCT00220519 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00220519 about?
NCT00220519 is a clinical study titled "Lactobacillus GG Supplementation During Pediatric Burn Injuries". Critical illness and the therapies that accompany it are associated with a disruption in the ecological equilibrium of the GI tract that can ultimately lead to infection. Lactobacillus GG, a probiotic, replenishes the healthy flora of the intestinal tract and may decrease the risk of diarrhea and in...
What is the current status of trial NCT00220519?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2004-10. Estimated completion is 2005-05.
What interventions are being tested in trial NCT00220519?
The interventions under investigation include: Lactobacillus GG (DRUG).
Who is sponsoring clinical trial NCT00220519?
This trial is sponsored by Shriners Hospitals for Children, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00220519's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia